Amanda Adler

17.4k total citations · 7 hit papers
166 papers, 10.1k citations indexed

About

Amanda Adler is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Amanda Adler has authored 166 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Endocrinology, Diabetes and Metabolism, 26 papers in Pulmonary and Respiratory Medicine and 22 papers in Epidemiology. Recurrent topics in Amanda Adler's work include Diabetes Treatment and Management (46 papers), Diabetes Management and Research (24 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Amanda Adler is often cited by papers focused on Diabetes Treatment and Management (46 papers), Diabetes Management and Research (24 papers) and Health Systems, Economic Evaluations, Quality of Life (18 papers). Amanda Adler collaborates with scholars based in United Kingdom, United States and Canada. Amanda Adler's co-authors include Richard Stevens, Rury R. Holman, Irene Stratton, C A Cull, Susan E. Manley, Rudy Bilous, Edward J. Boyko, Jessie H. Ahroni, Ravi Retnakaran and Kerensa Thorne and has published in prestigious journals such as The Lancet, JAMA and Nature Communications.

In The Last Decade

Amanda Adler

157 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

2000 1.5k citations Amanda Adler profile →
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)

2003 1.3k citations Amanda Adler, Rury R. Holman et al. profile →
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)

2001 875 citations Amanda Adler et al. profile →
Risk Factors for Renal Dysfunction in Type 2 Diabetes

2006 731 citations Ravi Retnakaran, Kerensa Thorne et al. Diabetes profile →
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)

2001 543 citations Amanda Adler, Rury R. Holman et al. profile →
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91)

2024 46 citations Amanda Adler, Ruth L. Coleman et al. profile →
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders

2025 17 citations Riccardo De Giorgi, Maxime Taquet et al. Nature Mental Health profile →

Peers

Countries citing papers authored by Amanda Adler

Since Specialization

Citations

This map shows the geographic impact of Amanda Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Adler more than expected).

Fields of papers citing papers by Amanda Adler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Adler. The network helps show where Amanda Adler may publish in the future.

Co-authorship network of co-authors of Amanda Adler

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Adler. A scholar is included among the top collaborators of Amanda Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Adler. Amanda Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A systematic review of in vivo brain insulin resistance biomarkers in humans 2025 ·Graham Reid, (unknown), Sarah Bauermeister, Amanda Adler, Ivan Koychev	1
2	Glucocorticoid‐induced hyperglycaemia in hospitalised adults: A matched cohort study (2013–2023) 2025 ·Diabetes Obesity and Metabolism ·Rajna Golubić, (unknown), Ruth L. Coleman, Rustam Rea, Rohini Mathur, Rishi Caleyachetty, Amanda Adler	0
3	Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events 2025 ·PLoS Medicine ·(unknown), Elaine Butterly, (unknown), (unknown), Naveed Sattar, Amanda Adler, David Phillippo, Sofia Dias, Nicky J. Welton, Andrew Clegg, Miles D. Witham, Kenneth Rockwood, David McAllister, Peter Hanlon	4
4	An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders breakdown → 2025 ·Nature Mental Health ·Riccardo De Giorgi, (unknown), (unknown), Maxime Taquet, Amanda Adler, Ivan Koychev, Rachel Upthegrove, Marco Solmi, Robert A. McCutcheon, Toby Pillinger, Philip J. Cowen, Catherine J. Harmer	17
5	Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children 2024 ·The Journal of Infectious Diseases ·Megan Files, Lauren E. Gentles, (unknown), Amanda Adler, Kirsten Lacombe, Jane A. Dickerson, Alexander L. Greninger, Alpana Waghmare, (unknown), Kimberly Pringle, Claire M. Midgley, Melissa Briggs Hagen, Janet A. Englund, Chetan Seshadri	0
6	12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study 2024 ·EClinicalMedicine ·Riccardo De Giorgi, Ivan Koychev, Amanda Adler, Philip J. Cowen, Catherine J. Harmer, Paul J. Harrison, Maxime Taquet	35
7	Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults 2024 ·BMJ Open ·Ivan Koychev, Amanda Adler, Paul Edison, Brian D. M. Tom, Joanne Milton, Joe Butchart, Adam Hampshire, Charles R. Marshall, Elizabeth Coulthard, Henrik Zetterberg, Peter J. Hellyer, Francesca Cormack, Benjamin R. Underwood, Catherine J. Mummery, Rury R. Holman	9
8	Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data 2024 ·BMJ ·Patrick Bidulka, David G. Lugo‐Palacios, (unknown), Stephen O’Neill, Amanda Adler, (unknown), Richard J. Silverwood, Jonathan W. Bartlett, Dorothea Nitsch, (unknown), Andrew Briggs, Liam Smeeth, Ian Douglas, Kamlesh Khunti, Richard Grieve	15
9	Glucocorticoid treatment and new‐onset hyperglycaemia and diabetes in people living with chronic obstructive pulmonary disease: A systematic review and meta‐analysis 2024 ·Diabetic Medicine ·Rajna Golubić, (unknown), (unknown), Andre Choo, Omer Baker, (unknown), (unknown), Arjun Raj, (unknown), Nay Aung, Niraj Kumar, (unknown), Ruth L. Coleman, Jeremy Tomlinson, Najib M. Rahman, Rishi Caleyachetty, Amanda Adler	0
10	Relationship of cardiorenal risk factors with albuminuria based on age, smoking, glycaemic status and BMI: a retrospective cohort study of the UK Biobank data 2023 ·SHILAP Revista de lepidopterología ·Debasish Kar, (unknown), Mintu Nath, Penny Breeze, (unknown), Mark Strong, J. Chilcott, Melanie J. Davies, Andrew Lee, Simon de Lusignan, Kamlesh Khunti, Amanda Adler, Elizabeth Goyder	2
11	Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89 2021 ·Diabetes Care ·Małgorzata Wamil, Ruth L. Coleman, Amanda Adler, John J.V. McMurray, Rury R. Holman	35
12	Impact of COVID-19 pandemic on HTA 2020 ·PharmacoEconomics & Outcomes News ·Paula Lorgelly, Amanda Adler	3
13	Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak 2020 ·Nature Communications ·Adam S. Dingens, Katharine H. D. Crawford, Amanda Adler, Sarah Steele, Karine Lacombe, Rachel Eguia, Fatima Amanat, Alexandra C. Walls, Caitlin R. Wolf, Michael Murphy, Deleah Pettie, Lauren Carter, Xuan Qin, Neil P. King, David Veesler, Florian Krammer, Jane A. Dickerson, Helen Y. Chu, Janet A. Englund, Jesse D. Bloom	44
14	In primary care, is measuring free-thyroxine plus thyroid-stimulating hormone to detect hypopituitarism cost-effective? A cost utility analysis using Markov chain models 2019 ·BMJ Open ·Brian Shine, Tim James, Amanda Adler	2
15	Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) 2018 ·Diabetes Obesity and Metabolism ·Shelby D. Reed, Yanhong Li, José Leal, Larry Radican, Amanda Adler, Joakim Alfredsson, John B. Buse, Jennifer B. Green, Keith D. Kaufman, (unknown), Frans Van de Werf, Eric D. Peterson, Alastair Gray, Rury R. Holman, (unknown)	4
16	NICE guidance on eluxadoline for treating irritable bowel syndrome with diarrhoea 2017 ·The Lancet. Gastroenterology & hepatology ·Amanda Adler	1
17	Association Between Glycated Haemoglobin and the Risk of Congestive Heart Failure in Diabetes Mellitus: Systematic Review and Meta-Analysis 2012 ·European Journal of Heart Failure ·Sebhat Erqou, C. Christine Lee, Matthew S. Suffoletto, Justin B. Echouffo‐Tcheugui, Rudolf A. de Boer, Joost P. van Melle, Amanda Adler	79
18	Screening for cystic fibrosis-related diabetes: a systematic review. 2012 ·Health Technology Assessment ·Norman Waugh, Pamela Royle, (unknown), Victoria Ho, Lekha Pandit, Paul Ewings, Amanda Adler, P Helms, Christopher Sheldon	43
19	368* Aetiology of erectile dysfunction in cystic fibrosis 2011 ·Journal of Cystic Fibrosis ·(unknown), (unknown), Helen Barker, A. Floto, Amanda Adler, (unknown), C. Murphy, Charles Haworth	2
20	Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74. (Diabetes (2006) 55, (1832-1839)) 2011 ·Diabetes ·Ravi Retnakaran, C A Cull, Kerensa Thorne, Amanda Adler, R R Holman	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact